Opal Capital’s Praxis Precision Medicines PRAX Stock Holding History

Opal Capital’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-996	Closed	-$318K	–	202
2025 Q4	$318K	Buy	+996	New	+$185K	0.08%	130

Other funds holding PRAX

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Opal Capital's PRAX Position: Q1 2026 in Review

Opal Capital sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 996 shares — an estimated $318K sold.

Opal Capital first reported a position in PRAX in Q4 2025 and held it in 1 quarter. The position peaked at $318K in Q4 2025. 291 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Opal Capital reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
Opal Capital sold 996 Praxis Precision Medicines shares in Q1 2026, an estimated $318K.
Opal Capital first reported a position in Praxis Precision Medicines in Q4 2025 and held it in 1 quarter.
Opal Capital's Praxis Precision Medicines position peaked at $318K in Q4 2025.
291 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Opal Capital's 13F filing for Q1 2026, filed 18 May 2026.